Survey 22 - Ortho practice and Pain ManagementMCI Registration NumberFULL NAME (As in your Pancard)EmailPhone/MobileCityStateSpecialityBank DetailsAccount Holder NameA/c NumberIFSC CodeUpload Cancelled Cheque (Max Size - 2 MB)Choose File Pancard NumberUpload Pancard Details (Max Size - 2 MB)Choose File Section 1: Prescribing Patterns for Pain Management1. Which of the following do you most commonly prescribe for mild to moderate musculoskeletal pain? Aceclofenac Paracetamol Serratiopeptidase Combination (Aceclofenac + Paracetamol) NSAIDs (other than Aceclofenac)2. For chronic inflammatory conditions (e.g., osteoarthritis, rheumatoid arthritis), which is your preferred choice? Aceclofenac Paracetamol Serratiopeptidase as adjuvant Combination therapy (Aceclofenac + Paracetamol + Serratiopeptidase) Other NSAIDs3. How often do you prescribe Serratiopeptidase in pain management? Frequently Occasionally Rarely Never4. What is your primary reason for prescribing Aceclofenac over other NSAIDs? Better efficacy Lower GI side effects Faster pain relief Cost-effectiveness Patient preference5. Do you combine Paracetamol with Aceclofenac for enhanced pain relief? Yes, frequently Only in severe cases Rarely NoSection 2: Perceptions on Efficacy and Safety6. How would you rate the efficacy of Aceclofenac in pain management? Excellent Good Moderate Poor7. In your experience, how effective is Serratiopeptidase in reducing inflammation and swelling? Highly effective Moderately effective Minimally effective Not effective8. Which patient population do you find benefits the most from Serratiopeptidase? Post-surgical pain Chronic osteoarthritis Acute musculoskeletal injury Rheumatoid arthritis Not sure9. What is your biggest concern with Aceclofenac? Gastrointestinal side effects Cardiovascular risks Renal toxicity Limited efficacy None10. Do you believe Paracetamol is sufficient as a standalone therapy for moderate pain? Yes, in most cases Only in mild pain No, needs combination Rarely effectiveSection 3: Combination Therapy and Patient Response11. Have you observed better outcomes with Aceclofenac + Paracetamol + Serratiopeptidase combinations compared to monotherapy? Yes, significantly better Slightly better No difference Worse outcomes12. What percentage of your patients report satisfactory pain relief with Aceclofenac alone? >70% 50-70% 30-50% <30%13. Do you adjust the dose of Aceclofenac based on patient comorbidities (e.g., renal/hepatic impairment)? Always Sometimes Rarely Never14. Which factor most influences your choice between Aceclofenac and other NSAIDs? Patient’s medical history Cost Side effect profile Clinical guidelines Personal experienceSection 4: Challenges and Future Perspectives15. What is the most common side effect you observe with Aceclofenac? Gastritis Dizziness Edema Hypertension None16. Do you face resistance from patients when prescribing Serratiopeptidase due to lack of awareness? Frequently Occasionally Rarely Never17. Should more clinical trials be conducted on Serratiopeptidase’s role in orthopaedic pain? Strongly agree Agree Neutral Disagree18. Would you recommend fixed-dose combinations (Aceclofenac + Paracetamol + Serratiopeptidase) as first-line therapy? Yes Only in specific cases No Unsure19. What additional therapies do you combine with these drugs for better pain management? Physiotherapy Opioids (in severe cases) Muscle relaxants Steroids None20. Based on your experience, which drug has the best safety profile among the three? Aceclofenac Paracetamol Serratiopeptidase All are similar I have read and agree to the Terms and Conditions .Submit Form